Literature DB >> 30609205

Multi-observer contouring of male pelvic anatomy: Highly variable agreement across conventional and emerging structures of interest.

Dale Roach1,2, Lois C Holloway1,2,3,4, Michael G Jameson1,2,3,4, Jason A Dowling1,3,5,6, Angel Kennedy7, Peter B Greer6,8, Michele Krawiec7, Robba Rai1,2,4, Jim Denham9, Jeremiah De Leon10, Karen Lim4,11, Megan E Berry4,11, Rohen T White7, Sean A Bydder7, Hendrick T Tan7, Jeremy D Croker12, Alycea McGrath7, John Matthews13, Robert J Smeenk14, Martin A Ebert3,7,15.   

Abstract

INTRODUCTION: This study quantified inter-observer contouring variations for multiple male pelvic structures, many of which are of emerging relevance for prostate cancer radiotherapy progression and toxicity response studies.
METHODS: Five prostate cancer patient datasets (CT and T2-weighted MR) were distributed to 13 observers for contouring. CT structures contoured included the clinical target volume (CTV), seminal vesicles, rectum, colon, bowel bag, bladder and peri-rectal space (PRS). MR contours included CTV, trigone, membranous urethra, penile bulb, neurovascular bundle and multiple pelvic floor muscles. Contouring variations were assessed using the intraclass correlation coefficient (ICC), Dice similarity coefficient (DSC), and multiple additional metrics.
RESULTS: Clinical target volume (CT and MR), bladder, rectum and PRS contours showed excellent inter-observer agreement (median ICC = 0.97; 0.99; 1.00; 0.95; 0.90, DSC = 0.83 ± 0.05; 0.88 ± 0.05; 0.93 ± 0.03; 0.81 ± 0.07; 0.80 ± 0.06, respectively). Seminal vesicle contours were more variable (ICC = 0.75, DSC = 0.73 ± 0.14), while colon and bowel bag contoured volumes were consistent (ICC = 0.97; 0.97), but displayed poor overlap (DSC = 0.58 ± 0.22; 0.67 ± 0.21). Smaller MR structures showed significant inter-observer variations, with poor overlap for trigone, membranous urethra, penile bulb, and left and right neurovascular bundles (DSC = 0.44 ± 0.22; 0.41 ± 0.21; 0.66 ± 0.21; 0.16 ± 0.17; 0.15 ± 0.15). Pelvic floor muscles recorded moderate to strong inter-observer agreement (ICC = 0.50-0.97), although large outlier variations were observed.
CONCLUSIONS: Inter-observer contouring variation was significant for multiple pelvic structures contoured on MR.
© 2019 The Royal Australian and New Zealand College of Radiologists.

Entities:  

Keywords:  contouring; delineation; inter/intra-observer variability; prostate

Mesh:

Year:  2019        PMID: 30609205     DOI: 10.1111/1754-9485.12844

Source DB:  PubMed          Journal:  J Med Imaging Radiat Oncol        ISSN: 1754-9477            Impact factor:   1.735


  6 in total

Review 1.  Treatment planning for proton therapy: what is needed in the next 10 years?

Authors:  Hakan Nystrom; Maria Fuglsang Jensen; Petra Witt Nystrom
Journal:  Br J Radiol       Date:  2019-08-07       Impact factor: 3.039

2.  Evaluation of daily online contour adaptation by radiation therapists for prostate cancer treatment on an MRI-guided linear accelerator.

Authors:  Thomas Willigenburg; Daan M de Muinck Keizer; Max Peters; An Claes; Jan J W Lagendijk; Hans C J de Boer; Jochem R N van der Voort van Zyp
Journal:  Clin Transl Radiat Oncol       Date:  2021-01-14

3.  Interrater agreement of contouring of the neurovascular bundles and internal pudendal arteries in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.

Authors:  F R Teunissen; R C Wortel; F J Wessels; A Claes; S M G van de Pol; M J A Rasing; R P Meijer; H H E van Melick; J C J de Boer; H M Verkooijen; J R N van der Voort van Zyp
Journal:  Clin Transl Radiat Oncol       Date:  2021-11-14

4.  Simulation CT-based radiomics for prediction of response after neoadjuvant chemo-radiotherapy in patients with locally advanced rectal cancer.

Authors:  Pierluigi Bonomo; Jairo Socarras Fernandez; Daniela Thorwarth; Marta Casati; Lorenzo Livi; Daniel Zips; Cihan Gani
Journal:  Radiat Oncol       Date:  2022-04-28       Impact factor: 4.309

5.  Daily online contouring and re-planning versus translation-only correction in neurovascular-sparing magnetic resonance-guided radiotherapy for localized prostate cancer.

Authors:  Frederik R Teunissen; Jochem R N van der Voort van Zyp; Eline N de Groot-van Breugel; Helena M Verkooijen; Ruud C Wortel; Johannes C J de Boer
Journal:  Phys Imaging Radiat Oncol       Date:  2022-09-13

6.  The urethral position may shift due to urethral catheter placement in the treatment planning for prostate radiation therapy.

Authors:  Yasuhiro Dekura; Kentaro Nishioka; Takayuki Hashimoto; Naoki Miyamoto; Ryusuke Suzuki; Takaaki Yoshimura; Ryuji Matsumoto; Takahiro Osawa; Takashige Abe; Yoichi M Ito; Nobuo Shinohara; Hiroki Shirato; Shinichi Shimizu
Journal:  Radiat Oncol       Date:  2019-12-12       Impact factor: 3.481

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.